LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year Low – Here’s Why

LeMaitre Vascular, Inc. (NASDAQ:LMAT) reached a new 52-week low during trading on Tuesday . The company traded as low as $78.39 and last traded at $78.9630, with a volume of 252422 shares trading hands. The stock had previously closed at $79.96.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on LMAT shares. Zacks Research cut shares of LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Wall Street Zen lowered LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Barrington Research downgraded LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 5th. Citizens Jmp upped their price objective on LeMaitre Vascular from $118.00 to $127.00 and gave the company a “market outperform” rating in a research note on Wednesday, May 6th. Finally, Citigroup reissued a “market outperform” rating on shares of LeMaitre Vascular in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, LeMaitre Vascular presently has a consensus rating of “Hold” and a consensus target price of $110.60.

LeMaitre Vascular Stock Performance

The business’s fifty day moving average price is $93.60 and its 200-day moving average price is $99.51. The company has a debt-to-equity ratio of 0.40, a current ratio of 16.31 and a quick ratio of 13.96. The stock has a market capitalization of $1.82 billion, a PE ratio of 28.00, a P/E/G ratio of 2.28 and a beta of 0.53.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.07). LeMaitre Vascular had a net margin of 25.02% and a return on equity of 15.63%. The firm had revenue of $70.38 million for the quarter, compared to analysts’ expectations of $71.47 million. During the same period in the prior year, the firm posted $0.60 EPS. LeMaitre Vascular’s revenue was up 9.6% on a year-over-year basis. As a group, equities research analysts expect that LeMaitre Vascular, Inc. will post 2.89 EPS for the current year.

LeMaitre Vascular Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $1.00 annualized dividend and a yield of 1.3%. LeMaitre Vascular’s dividend payout ratio (DPR) is currently 35.09%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of LMAT. Illinois Municipal Retirement Fund increased its holdings in LeMaitre Vascular by 1.1% in the fourth quarter. Illinois Municipal Retirement Fund now owns 11,171 shares of the medical instruments supplier’s stock valued at $906,000 after buying an additional 123 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in LeMaitre Vascular by 4.6% during the 4th quarter. NewEdge Advisors LLC now owns 3,158 shares of the medical instruments supplier’s stock worth $256,000 after buying an additional 139 shares during the last quarter. Federated Hermes Inc. lifted its holdings in LeMaitre Vascular by 0.4% during the 2nd quarter. Federated Hermes Inc. now owns 39,659 shares of the medical instruments supplier’s stock worth $3,294,000 after buying an additional 155 shares during the last quarter. Pictet Asset Management Holding SA boosted its holdings in LeMaitre Vascular by 5.5% in the first quarter. Pictet Asset Management Holding SA now owns 3,259 shares of the medical instruments supplier’s stock worth $356,000 after purchasing an additional 169 shares during the period. Finally, Sound Income Strategies LLC boosted its holdings in shares of LeMaitre Vascular by 425.6% in the 1st quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 183 shares during the period. 84.64% of the stock is currently owned by institutional investors.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.